152 related articles for article (PubMed ID: 38312765)
1. Pattern of Care of Recurrent Cervical Cancer in Low-resource Settings: Challenges and Patient-initiated Follow-up as a Novel Opportunity.
Barmon D; Tak A; Baruah U; Begum D; Gupta S; Khanikar D; Nath J; Yadav G
J Midlife Health; 2023; 14(3):205-211. PubMed ID: 38312765
[TBL] [Abstract][Full Text] [Related]
2. Patient initiated follow up in Obstetrics and Gynaecology: A systematic review.
Kershaw VF; Chainrai M; Radley SC
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():123-129. PubMed ID: 35303674
[TBL] [Abstract][Full Text] [Related]
3. British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU).
Newton C; Nordin A; Rolland P; Ind T; Larsen-Disney P; Martin-Hirsch P; Beaver K; Bolton H; Peevor R; Fernandes A; Kew F; Sengupta P; Miles T; Buckley L; Manderville H; Gajjar K; Morrison J; Ledermann J; Frost J; Lawrence A; Sundar S; Fotopoulou C
Int J Gynecol Cancer; 2020 May; 30(5):695-700. PubMed ID: 32312719
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
[TBL] [Abstract][Full Text] [Related]
5. Extended-field radiotherapy for locally advanced cervical cancer.
Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
[TBL] [Abstract][Full Text] [Related]
6. Patient initiated follow-up in cancer patients: A systematic review.
Newton C; Beaver K; Clegg A
Front Oncol; 2022; 12():954854. PubMed ID: 36313728
[TBL] [Abstract][Full Text] [Related]
7. Patient initiated follow up after gynaecological malignancy: National survey of current UK practice.
Coleman L; Newton C
Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():193-197. PubMed ID: 32240892
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.
Høeg BL; Bidstrup PE; Karlsen RV; Friberg AS; Albieri V; Dalton SO; Saltbæk L; Andersen KK; Horsboel TA; Johansen C
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31750936
[TBL] [Abstract][Full Text] [Related]
10. Optimising patient-initiated follow-up care - A qualitative analysis of women with breast cancer in the UK.
Moore L; Matheson L; Brett J; Lavender V; Kendall A; Lavery B; Watson E
Eur J Oncol Nurs; 2022 Oct; 60():102183. PubMed ID: 35932754
[TBL] [Abstract][Full Text] [Related]
11. Patient-initiated follow-up in gynaecology: Patient and clinician views.
Chainrai M; Kershaw VF; Gray TG; Radley SC
Eur J Obstet Gynecol Reprod Biol; 2024 May; 298():18-22. PubMed ID: 38705009
[TBL] [Abstract][Full Text] [Related]
12. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
[TBL] [Abstract][Full Text] [Related]
13. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
[TBL] [Abstract][Full Text] [Related]
14. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy.
Ittiamornlert P; Ruengkhachorn I
BMC Cancer; 2019 Jan; 19(1):51. PubMed ID: 30630439
[TBL] [Abstract][Full Text] [Related]
16. Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.
Auguste P; Barton P; Meads C; Davenport C; Małysiak S; Kowalska M; Zapalska A; Guest P; Martin-Hirsch P; Borowiack E; Khan K; Sundar S; Roberts T
BJOG; 2014 Mar; 121(4):464-76. PubMed ID: 24299112
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
18. Patient-Initiated Follow-Up in Ovarian Cancer.
Luk HM; Ngu SF; Lau LSK; Tse KY; Chu MMY; Kwok ST; Ngan HYS; Chan KKL
Curr Oncol; 2023 Mar; 30(4):3627-3636. PubMed ID: 37185389
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
